# CAVHANZA

NDC: 70709-192
Generic name: Nilotinib
Labeler / Manufacturer: Cycle Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20260630

FDA application: NDA217379

## Active ingredients

- NILOTINIB: 80 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70709-192"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70709-192
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98b197ea-bca4-427e-8737-97f70a3262bc